Piperazine derivatives with central pharmacological activity used as therapeutic tools
Authors:
- 27 August 2018
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 33 (1) , 13-24
Abstract
Medicinal chemistry is a science applied to the search and discovery of new therapeutic agents for the treatment of various diseases. Therefore, promising structures have been identified; one of these structures is the piperazine moiety, a cyclic molecule containing two nitrogen atoms in positions 1 and 4 as well as four carbon atoms. Many piperazine derivatives have central pharmacological activity that mainly involves the activation of the monoamine pathway. Thus, piperazine derivatives have been the subject of research for many central therapeutic applications, including antipsychotic, antidepressant and anxiolytic applications. Benzylpiperazine is the prototype of piperazine derivatives; this substance is the main component of recreational drugs, partly due to its stimulant and euphoric effects. This paper describes some piperazine derivatives used therapeutically as antipsychotic (clozapine), antidepressant (vortioxetine) and anxiolytic (buspirone) drugs.Keywords
This publication has 26 references indexed in Scilit:
- Neurobiology of Major Depressive DisorderNeural Plasticity, 2013
- New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophreniaBehavioural Brain Research, 2013
- Piperazine compounds as drugs of abuseDrug and Alcohol Dependence, 2012
- GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in miceBrain Research, 2010
- A comparison of 1-benzylpiperazine and methamphetamine in their acute effects on anxiety-related behavior of hooded ratsPharmacology Biochemistry and Behavior, 2009
- Review: Benzylpiperazine: a drug of abuse?Journal of Psychopharmacology, 2007
- Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporterBioorganic & Medicinal Chemistry Letters, 2004
- Structure-activity relationship studies of central nervous system (CNS) agents. 5. Effect of the hydrocarbon chain on the affinity of 4-substituted 1-(3-chlorophenyl)piperazines for 5-HT1A receptor sitesJournal of Medicinal Chemistry, 1992
- Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neuronsNaunyn-Schmiedeberg's Archives of Pharmacology, 1987
- Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agentsJournal of Medicinal Chemistry, 1986